Stamford Hospital partakes in trial of breakthrough breast cancer medication

Breast cancer doctors and patients are ecstatic that trials of a new drug were called off because the medication proved to be so successful. Breast cancer survivor Joyce Petre just found out she's been taking the breakthrough breast cancer drug Letrozole, brand name Femara, for two and a half years. Dr. Steven Lo says Joyce is one of nine Stamford Hospital patients who've been part of the national clinical trial the medication, with four patients on Letrozol and five on the placebo. Experts say the medication is killing cancer cells not destroyed by chemo or Tamoxifen. Based on the study of 5,000 women, those who got Letrozole had about half as many cancer recurrences than women who didn't.

sorry to interrupt
your first 20 are free
Access to News 12 is free for Optimum, Comcast®, Time Warner® and Service ElectricSM customers.
Please enjoy 20 complimentary views of articles, photos, and videos during the next 30 days.
you have reached your 5 view limit
Access to News 12 is free for Optimum, Comcast®, Time Warner® and Service ElectricSM customers.
Please login, create an account or subscribe to continue enjoying News12.
Our sign-up page is undergoing maintenance and is not currently available. However, you will be given direct access to news12.com while we complete our upgrade.
When we are back up and running you will be prompted at that time to complete your sign in. Until then, enjoy the local news, weather, traffic and more that's "as local as local news gets."